Dicerna Announces Pricing of Follow-On Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- US stocks set for lower open as Iran stalemate lifts oil, yields
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- L3Harris CEO steps down amid conduct review, shares drop
Dicerna Pharma (DRNA) Prices 2.7M Shares at $17.75/Share
May 21, 2015 9:29 AM EDTDicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) announced today the pricing of its underwritten registered public offering of 2,750,000 shares of its common stock at a price to the public of $17.75 per share. Closing of the offering is expected to occur on May 27, 2015, subject to customary closing... More
